Mustang Bio, Inc.
MBIO
$1.54
-$0.11-6.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -35.33% | 645.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 249.80% | 1,073.08% | |||
| Operating Income | -249.80% | -1,073.08% | |||
| Income Before Tax | -398.04% | 83.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -398.04% | 83.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -398.04% | 83.93% | |||
| EBIT | -249.80% | -1,073.08% | |||
| EBITDA | -304.11% | -384.42% | |||
| EPS Basic | -254.21% | 94.32% | |||
| Normalized Basic EPS | -254.49% | -159.43% | |||
| EPS Diluted | -254.21% | 94.32% | |||
| Normalized Diluted EPS | -254.49% | -159.43% | |||
| Average Basic Shares Outstanding | 40.56% | 182.81% | |||
| Average Diluted Shares Outstanding | 40.56% | 182.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||